BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34293829)

  • 1. Comprehensive analysis of BTN3A1 in cancers: mining of omics data and validation in patient samples and cellular models.
    Liang F; Zhang C; Guo H; Gao SH; Yang FY; Zhou GB; Wang GZ
    FEBS Open Bio; 2021 Sep; 11(9):2586-2599. PubMed ID: 34293829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.
    Salim M; Knowles TJ; Baker AT; Davey MS; Jeeves M; Sridhar P; Wilkie J; Willcox CR; Kadri H; Taher TE; Vantourout P; Hayday A; Mehellou Y; Mohammed F; Willcox BE
    ACS Chem Biol; 2017 Oct; 12(10):2631-2643. PubMed ID: 28862425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAP4-regulated dynein-dependent trafficking of BTN3A1 controls the TBK1-IRF3 signaling axis.
    Seo M; Lee SO; Kim JH; Hong Y; Kim S; Kim Y; Min DH; Kong YY; Shin J; Ahn K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14390-14395. PubMed ID: 27911820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
    Riganti C; Castella B; Massaia M
    Front Immunol; 2018; 9():1246. PubMed ID: 29937767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg].
    Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.
    Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ
    Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Roles for Coiled-Coil Dimers of Butyrophilin 3A1 in the Sensing of Prenyl Pyrophosphates by Human Vγ2Vδ2 T Cells.
    Wang H; Nada MH; Tanaka Y; Sakuraba S; Morita CT
    J Immunol; 2019 Aug; 203(3):607-626. PubMed ID: 31227581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression level of BTN3A1 on the surface of CD14
    Tomogane M; Omura M; Sano Y; Shimizu D; Toda Y; Hosogi S; Kimura S; Ashihara E
    Biochem Biophys Res Commun; 2022 Jan; 588():47-54. PubMed ID: 34952469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Activity Relationships of Butyrophilin 3 Ligands.
    Wiemer AJ
    ChemMedChem; 2020 Jun; 15(12):1030-1039. PubMed ID: 32453919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
    Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
    Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells.
    Wang H; Henry O; Distefano MD; Wang YC; Räikkönen J; Mönkkönen J; Tanaka Y; Morita CT
    J Immunol; 2013 Aug; 191(3):1029-42. PubMed ID: 23833237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Expressions of BTN3A1 and RhoB in Psoriasis Vulgaris Lesions by an Immunohistochemical Study.
    Tian Z; Wong W; Wu Q; Zhou J; Yan K; Chen J; Zhang Z
    Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):119-125. PubMed ID: 34545848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics analysis of the expression and prognostic value of the butyrophilins in breast cancer.
    Ren H; Li S; Liu X; Li W; Hao J; Zhao N
    J Leukoc Biol; 2021 Dec; 110(6):1181-1195. PubMed ID: 34411352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region.
    Nguyen K; Li J; Puthenveetil R; Lin X; Poe MM; Hsiao CC; Vinogradova O; Wiemer AJ
    FASEB J; 2017 Nov; 31(11):4697-4706. PubMed ID: 28705810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer.
    Cai P; Lu Z; Wu J; Qin X; Wang Z; Zhang Z; Zheng L; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2643-2654. PubMed ID: 31692043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of BTN3A1 on CD14
    Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
    Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
    Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrophilins: Dynamic Regulators of Protective T Cell Immunity in Cancer.
    Kumari R; Hosseini ES; Warrington KE; Milonas T; Payne KK
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1.
    Mattarei A; Enzinger M; Gu S; Karunakaran MM; Kimmel B; Berner N; Adams EJ; Herrmann T; Amslinger S
    Chemistry; 2017 Sep; 23(49):11945-11954. PubMed ID: 28631855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.